Lung transplant physician and critical care specialist Shruti Gadre, MD, shares insights into when patients with COPD are candidates for lung transplant.
Cleveland Clinic pulmonologists discuss the limitations of current modalities designed to treat emphysema and review the rationale, evidence and applications of valve therapy.
Inclusion of clinical data points could improve access to lung transplant for some cystic fibrosis and COPD patients.
Roflumilast’s benefit-to-harm ratio suggests that it only provides net benefit in patients at high risk of severe exacerbations.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The presence of chronic obstructive pulmonary disease in patients with chronic kidney disease greatly increases the risk of death, a Cleveland Clinic study has found. The results demonstrate the importance of closely monitoring chronic kidney disease patients with respiratory comorbidities.